CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 10  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0759
LYS 10.0648
GLU 20.0759
LEU 30.0556
ARG 40.0456
CYS 50.0309
GLN 60.0219
CYS 70.0150
ILE 80.0329
LYS 90.0029
THR 100.0122
TYR 110.0163
SER 120.0171
LYS 130.0160
PRO 140.0122
PHE 150.0056
HIS 160.0055
PRO 170.0049
LYS 180.0120
PHE 190.0103
ILE 200.0097
LYS 210.0144
GLU 220.0114
LEU 230.0126
ARG 240.0271
VAL 250.0262
ILE 260.0274
GLU 270.0425
SER 280.0407
GLY 290.0391
PRO 300.0276
HIS 310.0174
CYS 320.0286
ALA 330.0546
ASN 340.0400
THR 350.0331
GLU 360.0151
ILE 370.0156
ILE 380.0141
VAL 390.0128
LYS 400.0156
LEU 410.0149
SER 420.0196
ASP 430.0255
GLY 440.0257
ARG 450.0239
GLU 460.0193
LEU 470.0155
CYS 480.0137
LEU 490.0136
ASP 500.0168
PRO 510.0149
LYS 520.0157
GLU 530.0170
ASN 540.0163
TRP 550.0143
VAL 560.0102
GLN 570.0084
ARG 580.0112
VAL 590.0060
VAL 600.0033
GLU 610.0082
LYS 620.0116
PHE 630.0066
LEU 640.0096
LYS 650.0200
ARG 660.0221
ALA 670.0234
GLU 680.0295
ASN 690.0417

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.